10-K: Aveanna Healthcare Soars on Strong Earnings, Strategic Acquisitions

Sentiment:

Annual Report


Aveanna Healthcare Holdings Inc. reported a significant turnaround in net income for fiscal year 2025, driven by robust revenue growth across all segments and strategic acquisitions, despite ongoing regulatory and labor challenges.

Better than expectedNet income significantly improved from a loss of $10.9 million in fiscal year 2024 to a profit of $225.0 million in fiscal year 2025.Total revenue increased by a robust 20.2%, indicating strong demand and successful business strategies.Operating income surged by 83.5%, demonstrating enhanced operational efficiency and profitability.Adjusted EBITDA increased by 74.8%, reflecting substantial growth in core earnings.The weighted average interest rate on debt decreased from 9.2% to 7.3%, reducing financing costs.

Summary

  • Net income for fiscal year 2025 reached $225.0 million, a substantial improvement from a net loss of $10.9 million in fiscal year 2024.
  • Total revenue increased by 20.2% to $2,433.2 million in fiscal year 2025 from $2,024.5 million in fiscal year 2024.
  • Private Duty Services (PDS) revenue grew by 22.4% to $2,001.1 million, primarily due to an 11.0% increase in volume and an 11.4% increase in revenue rate.
  • Home Health & Hospice (HHH) revenue increased by 14.1% to $248.6 million, driven by an 11.3% rise in total episodes and a 3.5% increase in revenue per completed episode.
  • Medical Solutions (MS) revenue saw a 6.6% increase to $183.5 million, despite a 1.1% decline in volume, attributed to a 7.7% increase in revenue rate.
  • Gross margin improved by 27.5% to $810.5 million, with the gross margin percentage increasing from 31.4% to 33.3%.
  • Operating income surged by 83.5% to $256.5 million, representing 10.5% of revenue, up from 6.9% in the prior year.
  • Adjusted EBITDA increased by 74.8% to $320.9 million in fiscal year 2025 from $183.6 million in fiscal year 2024.
  • Successfully refinanced debt on September 17, 2025, reducing the weighted average interest rate from 9.2% to 7.3%.
  • Acquired Thrive Skilled Pediatric Care, LLC on June 2, 2025, for $75.7 million, expanding its footprint with 23 locations in seven states.
  • Entered into a definitive agreement on March 12, 2026, to acquire Family First Holding, LLC for $175.5 million, expected to close in Q2 2026.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, reflecting significant financial improvements, successful strategic acquisitions, and effective debt management, despite acknowledging ongoing industry challenges.

Positives

  • Achieved a significant net income of $225.0 million in fiscal year 2025, reversing a $10.9 million net loss from the previous year.
  • Reported strong consolidated revenue growth of 20.2% ($408.7 million increase) year-over-year.
  • PDS segment demonstrated robust growth with a 22.4% revenue increase, driven by both volume and revenue rate improvements.
  • HHH segment showed solid performance with a 14.1% revenue increase and improved patient mix.
  • Gross margin percentage improved by 1.9% to 33.3%, indicating better operational efficiency.
  • Operating income increased substantially by 83.5%, reflecting strong underlying business performance.
  • Adjusted EBITDA saw a significant increase of 74.8%, highlighting improved core operating profitability.
  • Successfully refinanced debt, leading to an $18.8 million decrease in net interest expense and a reduction in the weighted average interest rate from 9.2% to 7.3%.
  • Completed the acquisition of Thrive Skilled Pediatric Care, LLC, expanding geographic reach and service offerings.
  • Announced the planned acquisition of Family First Holding, LLC, further consolidating its position in pediatric home care.
  • Maintained effective internal control over financial reporting as of January 3, 2026, as audited by Ernst & Young LLP.

Negatives

  • Medical Solutions (MS) segment experienced a 1.1% decline in volume, partially offset by revenue rate increases.
  • Incurred a $5.9 million loss on debt extinguishment during fiscal year 2025 due to debt refinancing.
  • Corporate expenses increased by $37.9 million, or 30.2%, primarily due to professional services for refinancing and higher compensation costs.
  • Other expense was $6.4 million for fiscal year 2025, compared to other income of $21.4 million for fiscal year 2024, largely due to non-cash valuation losses on interest rate derivatives and lower net settlements.
  • CMS's final rule for fiscal year 2026 reduced Medicare reimbursement rates for home health by 1.3%.
  • The One Big Beautiful Bill Act (OBBBA) is projected to reduce federal Medicaid spending by $1.15 trillion over ten years, potentially impacting future Medicaid rate expansion.
  • The HHS rule on 'Ensuring Access to Medicaid Services' requires providers to spend a minimum of 80% of certain Medicaid payments on direct care workers by July 9, 2030, which could increase labor costs.
  • The home health and hospice industries face historical shortages in qualified employees and management, leading to increased labor costs and potential profitability reduction.
  • Ongoing grand jury subpoenas from the U.S. Department of Justice, Antitrust Division, regarding nurse wages and hiring activities, with an unpredictable outcome.
  • Civil Investigation Demand from the U.S. Department of Justice regarding Comfort Care Hospice, LLC for improper claims and remuneration, with an unpredictable outcome.

Risks

  • Intense competition among home health, hospice, and durable medical equipment companies.
  • Inability to maintain relationships with existing patient referral sources.
  • Reliance on third-party payers (Medicare, Medicaid, private insurance) for funding, with potential for reduced or limited reimbursement.
  • Changes to Medicare or Medicaid rates or payment methodologies, including alternative payment models like Medicare Advantage and managed Medicaid.
  • Downward pressure on reimbursement from the proliferation of Medicare Advantage plans.
  • Limited ability to control reimbursement rates for services.
  • Delays in collection or non-collection of patient accounts receivable, especially during business integration or system transitions.
  • Healthcare reform and other regulations, including proposed rules for the home health prospective payment system.
  • Changes in patient case-mix, payer mix, and payment methodologies affecting profitability.
  • Reduction in net reimbursement if value-based care programs are not effectively implemented.
  • Material adverse effects from public health emergencies, such as pandemics or infectious disease outbreaks.
  • Shortages in qualified employees and management, and competition for qualified personnel, increasing labor costs and reducing profitability.
  • Failure to maintain security and functionality of information systems or defend against cybersecurity attacks or breaches.
  • Substantial indebtedness increasing vulnerability to adverse economic conditions and limiting strategic alternatives.
  • Inability to identify, obtain financing for, acquire, and integrate strategic and accretive businesses or assets.
  • Risks related to legal proceedings, claims, and governmental inquiries, with potential for liability claims exceeding insurance coverage.
  • Impact of the 'One Big Beautiful Bill Act' (OBBBA) on Medicaid funding and eligibility.
  • Impact of the HHS rule 'Ensuring Access to Medicaid Services' on direct care worker compensation requirements.
  • Potential for increased competition if large national healthcare entities enter the home health or hospice market.
  • Inability to negotiate favorable managed care contracts or loss of existing contracts.
  • Negative impact on financial results from the industry trend toward value-based purchasing if quality of care is below expected outcomes or reporting requirements are not met.
  • Adverse effects on operating results if any hospice providers exceed annual Medicare caps.
  • Risks of business disruption associated with new business systems and technology initiatives, including potential defects or security vulnerabilities in software.
  • Failure of home health or hospice agencies to comply with Medicare program conditions of participation, leading to termination.
  • Inability to adequately obtain and maintain intellectual property and proprietary rights, or becoming subject to intellectual property disputes.
  • Exposure to interest rate risk due to variable rate indebtedness.
  • Federal regulation impairing ability to consummate acquisitions or open new branch locations (e.g., 36 Month Rule).
  • Professional liability and substantial damage awards due to the nature of the business.
  • Impairment in the carrying value of goodwill and intangible assets.
  • Inability to maintain corporate reputation or adverse publicity.
  • Sensitivity to regional weather conditions and other unforeseen events disrupting business.
  • Dependence on executive officers and other key employees.
  • Limitations on the ability to use net operating losses (NOLs) to offset future taxable income due to Section 382 of the Code.
  • Unanticipated changes in tax law or adverse outcomes from tax return examinations.
  • Failure to comply with federal, state, and local laws governing employment practices, including minimum wage and paid time-off requirements.
  • Potential dilution from future issuances of additional shares of common stock.
  • Anti-takeover provisions in governing documents and Delaware law making acquisitions more difficult.
  • Designation of specific courts as exclusive forum for certain litigation, potentially limiting stockholders' abilities to obtain favorable judicial forums.
  • Corporate opportunity doctrine not applying to Sponsors or their affiliates, potentially leading to competition or missed opportunities.
  • Decline in stock price if securities analysts do not publish research or issue unfavorable commentary.
  • Decline in stock price if operating and financial performance does not meet or exceed public guidance.

Future Outlook

The company expects to continue gaining market share in existing local markets through its 'virtuous cycle' strategy, leveraging its brand, service breadth, nurse recruiting, and go-to-market capabilities. It plans to accelerate growth through new workforce recruiting and training initiatives, de novo branch growth, and governmental affairs efforts to support competitive wages for nurses. The company believes it is well-positioned to benefit from the industry's shift towards value-based care models, aiming to improve future revenue and profitability by demonstrating cost savings and improved patient outcomes for payers. Strategic acquisitions, like the planned Family First Homecare deal, are a key part of expanding its Private Duty Services, Home Health, and Hospice presence. Ongoing investment in its platform is expected to drive efficiency, higher margins, and support growth initiatives based on value-based payment models.

Management Comments

  • Our platform creates sustainable competitive advantages that support our ability to continue driving rapid growth, both organically and through acquisitions, and positions us as the partner of choice for the patients we serve.
  • We believe our platform helps solve several of the most pressing challenges in healthcare today by delivering lower cost, high-quality care on a national scale to a medically complex, and often costly, patient base in the comfort of their own homes.
  • Our IMO team has developed a proven playbook over long merger and acquisition careers to lead the timely integration of our acquisitions while rapidly gaining synergies.
  • We believe that value-based care is the future of home health and have worked to equip ourselves to lead the transition.
  • We believe that Aveanna is uniquely well-positioned to benefit from a shift towards value-based care by virtue of our scale.
  • Our work to address this wage gap issue allows us to help support competitive wages for our nurses, which then contributes to growth as we are able to staff more cases and fill more hours that currently remain open.
  • Management does not believe the outcome of the DOJ Antitrust Division investigation will be material to the Company's results of operations or financial position.
  • Management believes that a loss event is not probable and that the Civil Investigation Demand regarding Comfort Care Hospice, LLC will not materially impact the Company's business, results of operations or financial position.

Industry Context

StockSavvy.ai notes that Aveanna Healthcare operates within a highly competitive and fragmented home care industry, characterized by intense competition from various providers ranging from local agencies to national entities. The industry is undergoing significant shifts towards value-based care models and increased scrutiny from government payers regarding reimbursement rates and compliance. The company's strategy of leveraging scale, technology, and a 'one-stop-shop' service offering positions it to capitalize on these trends, particularly as managed care organizations increasingly prefer larger, integrated providers. The ongoing labor shortages for qualified clinicians, as highlighted by Aveanna, are a pervasive industry challenge, impacting all healthcare providers and driving up labor costs. Regulatory changes, such as the OBBBA and the HHS rule on direct care worker compensation, reflect a broader governmental push for cost containment and quality improvement in Medicaid, which will necessitate adaptive strategies across the sector. Aveanna's proactive acquisition strategy, exemplified by the Thrive and Family First deals, is a common approach in fragmented markets to achieve scale and competitive advantage.

Comparison to Industry Standards

  • The 1.9% improvement in gross margin percentage to 33.3% for Aveanna Healthcare in fiscal year 2025 suggests strong operational efficiency compared to industry peers, especially given the challenging reimbursement environment.
  • The 74.8% increase in Adjusted EBITDA to $320.9 million indicates a significant outperformance in core profitability relative to many competitors who may be struggling with rising labor costs and stagnant reimbursement rates.
  • The reduction in weighted average interest rate from 9.2% to 7.3% through debt refinancing demonstrates effective capital management, potentially providing a cost of capital advantage over smaller, less capitalized competitors.
  • Aveanna's stated average of less than one patient safety-related injury per 2 million hours of service provided from 2017 to date suggests a high standard of patient safety and quality of care, which is a key differentiator in the competitive home health and hospice markets and likely exceeds the performance of many smaller, less resourced providers.
  • The company's ability to attract and integrate acquisitions like Thrive Skilled Pediatric Care, LLC (23 locations) and the planned acquisition of Family First Holding, LLC (27 locations) positions it as a consolidator in a fragmented market, a strategy often employed by industry leaders to gain market share and achieve economies of scale, similar to larger national healthcare entities.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Compliance OfficerNAPatrick A. CunninghamNAMentioned in context of Rule 10b5-1 trading arrangements, implying current role.
Chief Accounting OfficerNADeborah StewartNAMentioned in context of Rule 10b5-1 trading arrangements, implying current role.
Chief Financial OfficerNAMatthew BuckhalterNAMentioned in context of Rule 10b5-1 trading arrangements, implying current role.
Chief Executive OfficerNAJeff ShanerNAMentioned in context of Rule 10b5-1 trading arrangements, implying current role.
Chief Administrative OfficerNAEd ReiszNAMentioned in context of Rule 10b5-1 trading arrangements, implying current role.
General Counsel and Chief Legal OfficerNAJerry PerchikNAMentioned in context of Rule 10b5-1 trading arrangements, implying current role.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board Oversight of CybersecurityThe Audit Committee of the Board of Directors is tasked with providing oversight related to cybersecurity topics, receiving quarterly reports on incidents and key monitoring metrics from the Cybersecurity Steering Committee.NAEnhances corporate governance by ensuring high-level oversight of critical cybersecurity risks and responses.
Controlled Company ExemptionsThe company qualifies as a controlled company, allowing it to take advantage of exemptions from certain Nasdaq corporate governance rules, such as not requiring a majority independent board or fully independent compensation/nominating committees.NAMay limit the protections afforded to stockholders compared to companies subject to all corporate governance rules, potentially making common stock less attractive to some investors.
Corporate Opportunity Doctrine RenunciationThe Amended Charter renounces any interest or expectancy that the company has in, or right to be offered, specified business opportunities presented to the Sponsors or their affiliates (other than the company and its subsidiaries).NAAllows Sponsors and their affiliates to pursue opportunities that might otherwise be considered corporate opportunities for the company, potentially leading to competitive harm or missed beneficial transactions.
Exclusive Forum ProvisionsThe Amended Charter designates specific courts (Delaware Court of Chancery for internal corporate claims, federal district court for District of Delaware for Securities Act claims) as the exclusive forum for certain litigation.NAMay limit stockholders' ability to choose a favorable judicial forum for disputes, potentially discouraging lawsuits against the company and its directors/officers.
Anti-Takeover ProvisionsThe Amended Charter and Amended Bylaws include provisions such as a staggered board, limitations on special stockholder meetings, and supermajority voting requirements for certain amendments after the Sponsors' ownership drops below 50%.NACould delay or prevent hostile takeovers and changes in control or management, potentially limiting the opportunity for stockholders to receive a premium for their shares.
Code of Conduct and EthicsThe company has adopted a code of ethics applicable to all directors, officers, and employees, posted on its website.NAPromotes compliance with insider trading laws and ethical conduct across the organization.
Claw Back PolicyA Claw Back Policy became effective as of November 15, 2023.2023-11-15Enhances accountability for executive compensation in cases of financial restatements or misconduct.

Legal Proceedings

  • Arbitration award of $7.9 million against the company related to a Texas non-subscriber benefit plan claim, settled in May 2025, resulting in a net reduction to Cost of Revenue of $6.2 million.
  • Ongoing grand jury subpoenas from the U.S. Department of Justice, Antitrust Division, since October 2019, requesting documents and information pertaining to nurse wages, reimbursement rates, and hiring activities in certain local markets. Management cannot predict the timing or outcome but does not believe it will be material.
  • Civil Investigation Demand received on July 19, 2023, from the U.S. Department of Justice, United States Attorneys Office, Middle District of Alabama, regarding Comfort Care Hospice, LLC. The investigation concerns alleged improper submission of claims to Medicare and other federal healthcare programs and improper remuneration for patient referrals. Management believes a loss event is not probable and the matter will not materially impact the business.

Related Party Transactions

  • As of January 3, 2026, one of the company's significant shareholders owned 7.8% of the company's 2025 Term Loans.

Stakeholder Impact

  • **Shareholders**: Significant increase in net income and operating income, along with strategic acquisitions, could positively impact shareholder value. However, potential dilution from future stock issuances and the controlled company status might limit influence.
  • **Employees**: Labor shortages and increased competition for qualified personnel could lead to higher compensation and benefits, which is positive for employees but a cost pressure for the company. The company's I&E initiatives aim to foster a positive work environment.
  • **Patients and Families**: Expansion through acquisitions and focus on value-based care models aim to improve quality and access to home care services. The 'one stop shop' approach offers convenience and cost savings.
  • **Payers (Medicare, Medicaid, Managed Care)**: Regulatory changes like the OBBBA and the HHS rule on direct care worker compensation, along with Medicare rate reductions, will impact reimbursement. The company's focus on value-based care aims to align interests with payers by demonstrating cost savings and improved outcomes.
  • **Creditors**: Debt refinancing has reduced the weighted average interest rate, potentially improving the company's ability to service its substantial indebtedness. However, high leverage remains a risk.

Next Steps

  • Continue to gain market share in existing local markets through its 'virtuous cycle' strategy.
  • Expand capacity through new workforce recruiting and training initiatives.
  • Pursue de novo branch growth initiatives to expand geographic coverage.
  • Continue governmental affairs efforts to support competitive wages for nurses.
  • Leverage scale and capabilities to drive value-based care arrangements with Managed Care Organization payer partners.
  • Expand Private Duty Services, Home Health, and Hospice presence through strategic acquisitions, such as the planned acquisition of Family First Holding, LLC.
  • Cross-sell enteral services to its PDN and home care patient base.
  • Reinvest in its platform to optimize performance and deliver data-driven results.
  • Monitor and adapt to the implementation of the CY 2026 Home Health Prospective Payment System final rule and the 'One Big Beautiful Bill Act' (OBBBA).
  • Comply with the HHS rule 'Ensuring Access to Medicaid Services', particularly the 80% direct care worker compensation requirement by July 9, 2030.

Key Dates

DateDescription
2017-03Commenced operations in connection with the transformative merger of Epic Health Services Inc. and Pediatric Services of America, Inc.
2017-03-16Date of First Lien Credit Agreement.
2017-05-26Changed name to Aveanna Healthcare Holdings Inc.
2018-05-31CMS issued notice to launch Medicare pre-claim review (PCR) demonstration project (RCD).
2019-06CMS implemented the Review Choice Demonstration (RCD) for home health providers in Illinois, Ohio, Texas, North Carolina, and Florida.
2019-10-30Received grand jury subpoenas from the U.S. Department of Justice, Antitrust Division, regarding nurse wages, reimbursement rates, and hiring activities.
2020-01-01CMS implemented the Home Health Patient-Driven Groupings Model (PDGM) and changed payment unit from 60-day to 30-day periods.
2020-01-15Choice selection period began for home health agencies in Texas for the Review Choice Demonstration (RCD).
2020-02-13Choice selection period ended for home health agencies in Texas for the Review Choice Demonstration (RCD).
2021-04-05Health care providers became subject to information blocking restrictions pursuant to the 21st Century Cures Act.
2021-04-28Company's Board of Directors adopted the 2021 Employee Stock Purchase Plan (ESPP).
2021-04-29Commenced trading on the Nasdaq Stock Market.
2021-07-02Company's Board of Directors adopted the 2021 Stock Incentive Plan.
2021-09-01CMS began full implementation of RCD for Florida and North Carolina.
2021-11-12Entered into a Receivables Financing Agreement (Securitization Facility).
2022-01-01Home health providers required to submit a Notice of Admission (NOA) within five calendar days of admission.
2022-02-09Entered into interest rate cap agreements for an aggregate notional amount of $880.0 million.
2022-04-01CMS implemented 25% payment reduction in North Carolina and Florida for providers who selected minimal post-payment review under RCD.
2022-07-01Full 2% sequestration reduction on Medicare reimbursement in effect.
2023-01-01Expanded Home Health Value-Based Purchasing (HHVBP) model became effective in all 50 states.
2023-01-18Arbitration award in the amount of $7.9 million was rendered against the Company related to a Texas non-subscriber benefit plan claim.
2023-07-01Began paying a fixed rate of 2.03% under interest rate swap agreements.
2023-07-19Received a Civil Investigation Demand from the U.S. Department of Justice regarding Comfort Care Hospice, LLC.
2023-09Obtained a $9.1 million appellate bond with the trial court related to the arbitration award.
2023-11-15Claw Back Policy became effective.
2023-12-01CMS expanded the implementation of RCD to home health agencies operating in Oklahoma.
2024-05-10HHS published the final rule 'Ensuring Access to Medicaid Services'.
2024-05-17CMS extended RCD for demonstration states for an additional five years and removed the minimal review option with 25% payment reduction.
2024-12-09CMS promulgated revised regulations regarding the 60-day rule for identifying and returning Medicare and Medicaid overpayments.
2025-01-01First payment adjustment for expanded HHVBP model began, based on 2023 performance data. S-PAYGO 4% mandatory sequestration of Medicare benefit payments became effective.
2025-04-01Entered into an Agreement and Plan of Merger to acquire Thrive Skilled Pediatric Care, LLC.
2025-06-02Consummation of the Merger with Thrive Skilled Pediatric Care, LLC.
2025-06-09Court entered an agreed final judgment in the arbitration matter and ordered release of the bond.
2025-06-16Letters of credit securing the arbitration bond were released.
2025-06-25Amended the Securitization Facility to increase maximum amount available from $225.0 million to $275.0 million and extended termination date.
2025-06-30CMS issued its calendar year 2026 (CY 2026) proposed rule for the home health prospective payment system.
2025-07-04H.R. 1, the 'One Big Beautiful Bill Act' (OBBBA), was enacted into law.
2025-09-17Entered into the fourth joinder and twelfth amendment (Refinancing Amendment) to its First Lien Credit Agreement and terminated Second Lien Term Loan Facility.
2025-09-29Last quantitative goodwill impairment assessment date.
2025-11-28CMS released the final rule for fiscal year 2026, reducing Medicare reimbursement rates by 1.3%.
2025-12Sanctions within Stark Law updated to include significant civil penalties.
2026-01-03Fiscal year ended.
2026-03-12Announced definitive agreement to acquire Family First Holding, LLC.
2026-03-13Registrant had 217,510,046 shares of common stock outstanding.
2026-03-19Date of the Annual Report on Form 10-K filing.
2026-06-30Expiration date of interest rate swap agreements.
2026-07-01States required to publish updated FFS Medicaid fee schedule payment rates on a publicly available website (HHS Rule).
2026-12-31Most applicable provisions of OBBBA have implementation dates of December 31, 2026, or later.
2027-02-28Expiration date of interest rate cap agreements.
2027-07-09States must generally report on data collection readiness for direct care worker compensation (HHS Rule).
2028-01-01HHA performance in 2026 will determine payments in 2028 (HHVBP).
2028-04-15Effectively extended maturity date of Existing Revolving Credit Facility.
2028-06-25Scheduled termination date of the Securitization Facility.
2028-07-09States must generally report on actual payment percentages for direct care worker compensation (HHS Rule).
2029-05-31Review Choice Demonstration (RCD) Demonstration Project runs until this date.
2030-07-09States generally ensure providers spend minimum 80% of Medicaid payments for certain services on direct care workers (HHS Rule).
2030-09-17Maturity date for loans and commitments under the 2025 Refinancing Revolving Credit Facility.
2032-09-17Maturity date for loans and commitments under the 2025 Refinancing Term Facility.

Recommendation

buy

The company demonstrated exceptional financial performance in fiscal year 2025, reversing a net loss to a substantial profit and achieving strong revenue and Adjusted EBITDA growth. The successful debt refinancing significantly reduced interest expenses, improving the company's financial health. Strategic acquisitions, both completed and planned, indicate a clear growth trajectory and market consolidation efforts. While regulatory pressures and labor market challenges exist, the company's robust operational improvements, focus on value-based care, and strong management execution suggest a positive outlook for future performance and shareholder value.

Keywords

Home Healthcare, Private Duty Nursing, Hospice, Medical Solutions, Pediatric Care, Elderly Care, SEC Filing, 10-K, Financial Results, Revenue Growth, Net Income, Adjusted EBITDA, Acquisitions, Thrive Skilled Pediatric Care, Family First Homecare, Debt Refinancing, Medicare, Medicaid, Healthcare Regulation, Labor Shortages, Cybersecurity, Corporate Governance, AVAH

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.